Applications of IVIVC in Formulation Development - PQRI

More documents

Recommendations

Info

IVIVCs – Lessons Learned FDA guidance is just that, not a regulation or requirement, but it is in the best interest of sponsor to evaluate feasibility Terminology in the guidance indicates sponsors are allowed some flexibility in developing IVIVCs Collaboration among various functional groups a necessity (formulations, analytical, clinical, regulatory, biopharmaceutics) Timing “Developing IVIVCs is not a science, it is an art.”
Acknowledgements Pharmaceutical Sciences Robin Enever Technical Services Stephen White Mike Dey John Pendregast Richard DeNeale Biopharmaceutics Sridhar Duvvuri Clinical Phil Mayer William McKeand Formulations Alice Nichols Ron Warner Steven Troy John Michelucci Deborah Sherman Regulatory David Korman John Clark James Murphy Shaleish Singh Simon Golec Chris Diorio Beth Kendsersky Ian Armstrong Chris Le Analytical Services Andy Beath Lusan Yao Patricia Mann Brian Spencer Marijo Weinzierl Quality Operations Joe DeVito David Sheats Deborah Parker Consultants Lewis Leeson Scott Stevens William Barr William Jock Mario Gonzalez
Page 1 and 2:
Application of IVIVCs in Formulatio
Page 3 and 4:
Applications of IVIVC Understandin
Page 5 and 6:
Practical Application: In Vivo and
Page 7 and 8:
Plasma Concentrations Following Ora
Page 9 and 10:
IVIVC Model - Water as Dissolution
Page 11 and 12: Level A IVIVC Validation - Water as
Page 13 and 14: IVIVC Model - Acetate Buffer as Dis
Page 15 and 16: Dissolution of Target Formulation -
Page 17 and 18: Level A IVIVC Validation - Acetate
Page 19 and 20: Case Study 2 BCS Class II Drug Hi
Page 21 and 22: Dissolution of Low Dose Reformulati
Page 23 and 24: Mean Dissolution and Absorption Pro
Page 25 and 26: Internal and External Predictabilit
Page 27 and 28: Dissolution Specifications For Low
Page 29 and 30: % Polymer Prediction Model to Achie
Page 31 and 32: Case Study 3 BCS Class I Drug Dev
Page 33 and 34: In Vitro / In Vivo Relationship for
Page 35 and 36: Demonstration of in vitro release i
Page 37 and 38: Internal Predictability Measures of
Page 39 and 40: MR Tablet Dissolution Profiles in 0
Page 41 and 42: 200 mg MR Tablet Dissolution Profil
Page 45 and 46: Approaches to a Level A IVIVC Trad
Page 47 and 48: MR Tablet Dissolution Profiles (Cum
Page 49 and 50: MR Tablets Absorption Profiles (Cum
Page 53 and 54: INTERNAL AND EXTERNAL PREDICTABILIT
Page 55 and 56: Case Study 5 BCS Class I Drug Dev
Page 57 and 58: Model of Fraction of Drug Absorbed
Page 59 and 60: Validation of the Model
Page 61: Conclusions-Benefits of IVIVC Prov
show all

Applications of IVIVC in Formulation Development - PQRI

Create successful ePaper yourself

Delete template?

Save as template?